Semax is a synthetic nootropic peptide analog of endogenous adrenocorticotropic hormone (ACTH) fragment, primarily studied for its cognitive-enhancing and neuroprotective properties. Clinically, it is often administered intranasally to facilitate direct passage across the blood-brain barrier for central nervous system effects. We observe its utility in supporting neural resilience.
Origin
Semax originated from Russian pharmacological research, derived from the structure of the peptide Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPG), a fragment of ACTH. Its nomenclature reflects its development as a synthetic agent targeting neurological function.
Mechanism
The mechanism involves modulating the levels of several key neurotransmitters, including dopamine and serotonin, within the brain, while also promoting the synthesis of Brain-Derived Neurotrophic Factor (BDNF). Furthermore, Semax appears to inhibit the enzymatic breakdown of enkephalins, which contribute to its purported anxiolytic and cognitive benefits. This multifaceted action supports synaptic plasticity and neuronal survival.
Peptide therapies, integrated with wellness practices, restore the specific cellular signals required to resolve the systemic bioenergetic deficits that manifest as mental fatigue.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.